If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it? View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2021-10-14

AUTHORS

Gary R. Cutter, Donald B. Sanders

ABSTRACT

In this issue of Neurotherapeutics, Li et.al. report a large retrospective study of the beneficial effects of thymectomy on the progression of ocular myasthenia gravis (OMG) to generalized MG (GMG) (Huanhuan et al. in Neurotherapeutics XX, 2021). This paper demonstrates a more than 50% reduction in the risk of GMG when a thymectomy was performed on these patients. The authors conclude with the recommendation that well-designed clinical trials be performed to evaluate the potential that thymectomy in OMG reduces the burden of GMG. More... »

PAGES

1-2

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13311-021-01139-x

DOI

http://dx.doi.org/10.1007/s13311-021-01139-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1141884962

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34651292


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA", 
          "id": "http://www.grid.ac/institutes/grid.265892.2", 
          "name": [
            "Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cutter", 
        "givenName": "Gary R.", 
        "id": "sg:person.011066731317.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011066731317.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurology Duke University Medical Center, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.189509.c", 
          "name": [
            "Department of Neurology Duke University Medical Center, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sanders", 
        "givenName": "Donald B.", 
        "id": "sg:person.014733214412.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014733214412.73"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2021-10-14", 
    "datePublishedReg": "2021-10-14", 
    "description": "In this issue of Neurotherapeutics, Li et.al. report a large retrospective study of the beneficial effects of thymectomy on the progression of ocular myasthenia gravis (OMG) to generalized MG (GMG) (Huanhuan et al. in Neurotherapeutics XX, 2021). This paper demonstrates a more than 50% reduction in the risk of GMG when a thymectomy was performed on these patients. The authors conclude with the recommendation that well-designed clinical trials be performed to evaluate the potential that thymectomy in OMG reduces the burden of GMG.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13311-021-01139-x", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1294839", 
        "issn": [
          "1933-7213", 
          "1878-7479"
        ], 
        "name": "Neurotherapeutics", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "ocular myasthenia gravis", 
      "myasthenia gravis", 
      "generalized myasthenia gravis", 
      "risk of progression", 
      "large retrospective study", 
      "retrospective study", 
      "clinical trials", 
      "thymectomy", 
      "beneficial effects", 
      "gravis", 
      "progression", 
      "risk", 
      "patients", 
      "GMG", 
      "neurotherapeutics", 
      "trials", 
      "burden", 
      "recommendations", 
      "study", 
      "reduction", 
      "effect", 
      "potential", 
      "authors", 
      "et", 
      "issues", 
      "Mg", 
      "Li et", 
      "paper", 
      "issue of Neurotherapeutics", 
      "risk of GMG", 
      "burden of GMG"
    ], 
    "name": "If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it?", 
    "pagination": "1-2", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1141884962"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13311-021-01139-x"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34651292"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13311-021-01139-x", 
      "https://app.dimensions.ai/details/publication/pub.1141884962"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T19:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_896.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13311-021-01139-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13311-021-01139-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13311-021-01139-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13311-021-01139-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13311-021-01139-x'


 

This table displays all metadata directly associated to this object as RDF triples.

97 TRIPLES      21 PREDICATES      55 URIs      47 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13311-021-01139-x schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N0cf265433f0b445bb86ad6cac0855644
4 schema:datePublished 2021-10-14
5 schema:datePublishedReg 2021-10-14
6 schema:description In this issue of Neurotherapeutics, Li et.al. report a large retrospective study of the beneficial effects of thymectomy on the progression of ocular myasthenia gravis (OMG) to generalized MG (GMG) (Huanhuan et al. in Neurotherapeutics XX, 2021). This paper demonstrates a more than 50% reduction in the risk of GMG when a thymectomy was performed on these patients. The authors conclude with the recommendation that well-designed clinical trials be performed to evaluate the potential that thymectomy in OMG reduces the burden of GMG.
7 schema:genre article
8 schema:inLanguage en
9 schema:isAccessibleForFree false
10 schema:isPartOf sg:journal.1294839
11 schema:keywords GMG
12 Li et
13 Mg
14 authors
15 beneficial effects
16 burden
17 burden of GMG
18 clinical trials
19 effect
20 et
21 generalized myasthenia gravis
22 gravis
23 issue of Neurotherapeutics
24 issues
25 large retrospective study
26 myasthenia gravis
27 neurotherapeutics
28 ocular myasthenia gravis
29 paper
30 patients
31 potential
32 progression
33 recommendations
34 reduction
35 retrospective study
36 risk
37 risk of GMG
38 risk of progression
39 study
40 thymectomy
41 trials
42 schema:name If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it?
43 schema:pagination 1-2
44 schema:productId N6a8bf23a193846c19e06677df77a5728
45 N79877279473d4eb9b294015009195727
46 Na16f095335cc4d2386dbe016a20974f7
47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1141884962
48 https://doi.org/10.1007/s13311-021-01139-x
49 schema:sdDatePublished 2022-01-01T19:02
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher N97ba0616a5c14520bdea8a75fa51bd1d
52 schema:url https://doi.org/10.1007/s13311-021-01139-x
53 sgo:license sg:explorer/license/
54 sgo:sdDataset articles
55 rdf:type schema:ScholarlyArticle
56 N06925c6ea6a94fd58dec0b842db954a3 rdf:first sg:person.014733214412.73
57 rdf:rest rdf:nil
58 N0cf265433f0b445bb86ad6cac0855644 rdf:first sg:person.011066731317.82
59 rdf:rest N06925c6ea6a94fd58dec0b842db954a3
60 N6a8bf23a193846c19e06677df77a5728 schema:name dimensions_id
61 schema:value pub.1141884962
62 rdf:type schema:PropertyValue
63 N79877279473d4eb9b294015009195727 schema:name pubmed_id
64 schema:value 34651292
65 rdf:type schema:PropertyValue
66 N97ba0616a5c14520bdea8a75fa51bd1d schema:name Springer Nature - SN SciGraph project
67 rdf:type schema:Organization
68 Na16f095335cc4d2386dbe016a20974f7 schema:name doi
69 schema:value 10.1007/s13311-021-01139-x
70 rdf:type schema:PropertyValue
71 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
72 schema:name Medical and Health Sciences
73 rdf:type schema:DefinedTerm
74 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
75 schema:name Clinical Sciences
76 rdf:type schema:DefinedTerm
77 sg:journal.1294839 schema:issn 1878-7479
78 1933-7213
79 schema:name Neurotherapeutics
80 schema:publisher Springer Nature
81 rdf:type schema:Periodical
82 sg:person.011066731317.82 schema:affiliation grid-institutes:grid.265892.2
83 schema:familyName Cutter
84 schema:givenName Gary R.
85 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011066731317.82
86 rdf:type schema:Person
87 sg:person.014733214412.73 schema:affiliation grid-institutes:grid.189509.c
88 schema:familyName Sanders
89 schema:givenName Donald B.
90 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014733214412.73
91 rdf:type schema:Person
92 grid-institutes:grid.189509.c schema:alternateName Department of Neurology Duke University Medical Center, Durham, NC, USA
93 schema:name Department of Neurology Duke University Medical Center, Durham, NC, USA
94 rdf:type schema:Organization
95 grid-institutes:grid.265892.2 schema:alternateName Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
96 schema:name Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
97 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...